» Articles » PMID: 12297829

Relevance of Niemann-Pick Type C1 Protein Expression in Controlling Plasma Cholesterol and Biliary Lipid Secretion in Mice

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2002 Sep 26
PMID 12297829
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Receptor-mediated endocytosis is one of the major mechanisms for uptake of lipoprotein cholesterol in the liver. Because Niemann-Pick C1 (NPC1) protein is a key component in the intracellular distribution of cholesterol obtained from lipoproteins by the endocytic pathway, it may play a critical role in controlling plasma lipoprotein cholesterol and its biliary secretion. A murine model of Niemann-Pick type C disease (NPC), the NPC1-deficient [NPC1 (-/-)] mouse, was used to evaluate the relevance of hepatic NPC1 expression in regulating plasma lipoprotein cholesterol profile and biliary lipid secretion under chow and high-cholesterol diets. Total plasma cholesterol concentrations were increased in NPC1 (-/-) mice compared with wild-type mice when both mouse strains were fed chow or high-cholesterol diets. The increased plasma cholesterol levels found in NPC1 (-/-) mice were mostly due to elevated cholesterol content in larger and more heterogeneous HDL particles. On the chow diet, biliary lipid secretion was not impaired by NPC1 deficiency. Furthermore, chow-fed NPC1 (-/-) mice showed a small, but significant, increase in biliary cholesterol secretion. On the high-cholesterol diet, wild-type mice increased biliary cholesterol output, whereas NPC1 (-/-) mice did not. Finally, hepatic NPC1 overexpression by adenovirus-mediated gene transfer increased biliary cholesterol secretion by 100% to 150% in both wild-type mice and cholesterol-fed NPC1 (-/-) mice. In conclusion, hepatic NPC1 expression is an important factor for regulating plasma HDL cholesterol levels and biliary cholesterol secretion in mice.

Citing Articles

Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase.

Sachdev V, Duta-Mare M, Korbelius M, Vujic N, Leopold C, de Boer J Cells. 2021; 10(10).

PMID: 34685599 PMC: 8533808. DOI: 10.3390/cells10102619.


Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk.

Regan J, Shah S Curr Cardiol Rep. 2020; 22(12):174.

PMID: 33040225 PMC: 8133795. DOI: 10.1007/s11886-020-01422-x.


Delineation of metabolic responses of Npc1 mice lacking the cholesterol-esterifying enzyme SOAT2 to acute treatment with 2-hydroxypropyl-β-cyclodextrin.

Ramirez C, Taylor A, Lopez A, Repa J, Turley S Steroids. 2020; 164:108725.

PMID: 32890578 PMC: 7680374. DOI: 10.1016/j.steroids.2020.108725.


Ontogenesis and Modulation of Intestinal Unesterified Cholesterol Sequestration in a Mouse Model of Niemann-Pick C1 Disease.

Lopez A, Ramirez C, Taylor A, Jones R, Repa J, Turley S Dig Dis Sci. 2019; 65(1):158-167.

PMID: 31312996 DOI: 10.1007/s10620-019-05736-x.


Hepatic and neuronal phenotype of NPC1 mice.

Santiago-Mujica E, Flunkert S, Rabl R, Neddens J, Loeffler T, Hutter-Paier B Heliyon. 2019; 5(3):e01293.

PMID: 30923761 PMC: 6423819. DOI: 10.1016/j.heliyon.2019.e01293.